MedTrace Logo

Validation of Novel BTE and SP Hearing Aid Models

NCT04882787 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2024-08-12

Study results available
· View outcomes & findings →

Summary

Participants will wear one set of 2 different BTE hearing aid models based on the gain required by their hearing loss. The hearing aids will be programmed based on a prescriptive approach and participants will be sent out for either one home trial with the less powerful BTEs or for two home trials with the SP (super power) BTEs.

Conditions

Interventions

DEVICE

BTE hearing aid

Amplification

Sponsors & Collaborators

  • Sonova Canada Inc.

    collaborator INDUSTRY

  • Sonova AG

    lead INDUSTRY

Principal Investigators

  • Jinyu Qian, PhD · Sonova AG

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-14
Primary Completion
2021-07-13
Completion
2021-07-13

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04882787 on ClinicalTrials.gov